The United States has doubled its investment – to nearly US$1 billion – to expedite development of a potential COVID-19 vaccine by American firm Moderna, which on Monday (Jul 26) begins the decisive final phase of clinical trials.
US doubles spending on potential virus vaccine to nearly US$1 billion
